These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36764586)

  • 1. SS148 and WZ16 inhibit the activities of nsp10-nsp16 complexes from all seven human pathogenic coronaviruses.
    Li F; Ghiabi P; Hajian T; Klima M; Li ASM; Khalili Yazdi A; Chau I; Loppnau P; Kutera M; Seitova A; Bolotokova A; Hutchinson A; Perveen S; Boura E; Vedadi M
    Biochim Biophys Acta Gen Subj; 2023 Apr; 1867(4):130319. PubMed ID: 36764586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of SARS-CoV-2 nsp10-nsp16 in complex with small molecule inhibitors, SS148 and WZ16.
    Klima M; Khalili Yazdi A; Li F; Chau I; Hajian T; Bolotokova A; Kaniskan HÜ; Han Y; Wang K; Li D; Luo M; Jin J; Boura E; Vedadi M
    Protein Sci; 2022 Sep; 31(9):e4395. PubMed ID: 36040262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A High-Throughput Radioactivity-Based Assay for Screening SARS-CoV-2 nsp10-nsp16 Complex.
    Khalili Yazdi A; Li F; Devkota K; Perveen S; Ghiabi P; Hajian T; Bolotokova A; Vedadi M
    SLAS Discov; 2021 Jul; 26(6):757-765. PubMed ID: 33874769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and functional insights into the 2'-O-methyltransferase of SARS-CoV-2.
    Deng J; Gong F; Li Y; Tan X; Liu X; Yang S; Chen X; Wang H; Liu Q; Shen C; Zhou L; Chen Y
    Virol Sin; 2024 Aug; 39(4):619-631. PubMed ID: 38969340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview on the seven pathogenic human coronaviruses.
    Kesheh MM; Hosseini P; Soltani S; Zandi M
    Rev Med Virol; 2022 Mar; 32(2):e2282. PubMed ID: 34339073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A High-Throughput RNA Displacement Assay for Screening SARS-CoV-2 nsp10-nsp16 Complex toward Developing Therapeutics for COVID-19.
    Perveen S; Khalili Yazdi A; Devkota K; Li F; Ghiabi P; Hajian T; Loppnau P; Bolotokova A; Vedadi M
    SLAS Discov; 2021 Jun; 26(5):620-627. PubMed ID: 33423577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronavirus nsp10/nsp16 Methyltransferase Can Be Targeted by nsp10-Derived Peptide In Vitro and In Vivo To Reduce Replication and Pathogenesis.
    Wang Y; Sun Y; Wu A; Xu S; Pan R; Zeng C; Jin X; Ge X; Shi Z; Ahola T; Chen Y; Guo D
    J Virol; 2015 Aug; 89(16):8416-27. PubMed ID: 26041293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NSP16 2'-O-MTase in Coronavirus Pathogenesis: Possible Prevention and Treatments Strategies.
    Chang LJ; Chen TH
    Viruses; 2021 Mar; 13(4):. PubMed ID: 33804957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of the Methyl Donor
    Aouadi W; Blanjoie A; Vasseur JJ; Debart F; Canard B; Decroly E
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28031370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging variants of SARS-CoV-2 NSP10 highlight strong functional conservation of its binding to two non-structural proteins, NSP14 and NSP16.
    Wang H; Rizvi SRA; Dong D; Lou J; Wang Q; Sopipong W; Su Y; Najar F; Agarwal PK; Kozielski F; Haider S
    Elife; 2023 Dec; 12():. PubMed ID: 38127066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and structural insights into the mechanisms of SARS coronavirus RNA ribose 2'-O-methylation by nsp16/nsp10 protein complex.
    Chen Y; Su C; Ke M; Jin X; Xu L; Zhang Z; Wu A; Sun Y; Yang Z; Tien P; Ahola T; Liang Y; Liu X; Guo D
    PLoS Pathog; 2011 Oct; 7(10):e1002294. PubMed ID: 22022266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conserved protein targets for developing pan-coronavirus drugs based on sequence and 3D structure similarity analyses.
    Ma M; Yang Y; Wu L; Zhou L; Shi Y; Han J; Xu Z; Zhu W
    Comput Biol Med; 2022 Jun; 145():105455. PubMed ID: 35364304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronavirus Nsp10, a critical co-factor for activation of multiple replicative enzymes.
    Bouvet M; Lugari A; Posthuma CC; Zevenhoven JC; Bernard S; Betzi S; Imbert I; Canard B; Guillemot JC; Lécine P; Pfefferle S; Drosten C; Snijder EJ; Decroly E; Morelli X
    J Biol Chem; 2014 Sep; 289(37):25783-96. PubMed ID: 25074927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of critical protein-protein interactions of SARS-CoV-2 capping and proofreading molecular machineries towards designing dual target inhibitory peptides.
    Arabi-Jeshvaghani F; Javadi-Zarnaghi F; Ganjalikhany MR
    Sci Rep; 2023 Jan; 13(1):350. PubMed ID: 36611052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short peptides derived from the interaction domain of SARS coronavirus nonstructural protein nsp10 can suppress the 2'-O-methyltransferase activity of nsp10/nsp16 complex.
    Ke M; Chen Y; Wu A; Sun Y; Su C; Wu H; Jin X; Tao J; Wang Y; Ma X; Pan JA; Guo D
    Virus Res; 2012 Aug; 167(2):322-8. PubMed ID: 22659295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virtual screening, ADME/T, and binding free energy analysis of anti-viral, anti-protease, and anti-infectious compounds against NSP10/NSP16 methyltransferase and main protease of SARS CoV-2.
    Maurya SK; Maurya AK; Mishra N; Siddique HR
    J Recept Signal Transduct Res; 2020 Dec; 40(6):605-612. PubMed ID: 32476594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refolding of lid subdomain of SARS-CoV-2 nsp14 upon nsp10 interaction releases exonuclease activity.
    Czarna A; Plewka J; Kresik L; Matsuda A; Karim A; Robinson C; O'Byrne S; Cunningham F; Georgiou I; Wilk P; Pachota M; Popowicz G; Wyatt PG; Dubin G; Pyrć K
    Structure; 2022 Aug; 30(8):1050-1054.e2. PubMed ID: 35609600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of naphthyridine and quinoline derivatives as potential Nsp16-Nsp10 inhibitors: a pharmacoinformatics study.
    Aldahham BJM; Al-Khafaji K; Saleh MY; Abdelhakem AM; Alanazi AM; Islam MA
    J Biomol Struct Dyn; 2022 Jun; 40(9):3899-3906. PubMed ID: 33252031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Interactions of Zyesami with the SARS-CoV-2 nsp10/nsp16 Protein Complex.
    Alnomasy SF; Alotaibi BS; Aldosari ZM; Mujamammi AH; Alzamami A; Anand P; Akhter Y; Khan FR; Hasan MR
    Comb Chem High Throughput Screen; 2023; 26(6):1196-1203. PubMed ID: 35975856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural Basis for Inhibition of the SARS-CoV-2 nsp16 by Substrate-Based Dual Site Inhibitors.
    Kalnins G; Rudusa L; Bula AL; Zelencova-Gopejenko D; Bobileva O; Sisovs M; Tars K; Jirgensons A; Jaudzems K; Bobrovs R
    ChemMedChem; 2024 Dec; 19(24):e202400618. PubMed ID: 39258386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.